168 related articles for article (PubMed ID: 17162713)
1. Effect of short-term, low-dose treatment with tamoxifen in patients with primary dysmenorrhea.
Pierzyński P; Swiatecka J; Oczeretko E; Laudański P; Batra S; Laudański T
Gynecol Endocrinol; 2006 Dec; 22(12):698-703. PubMed ID: 17162713
[TBL] [Abstract][Full Text] [Related]
2. The influence of a combined oral contraceptive on uterine activity and reactivity to agonists in primary dysmenorrhea.
Hauksson A; Ekström P; Juchnicka E; Laudański T; Akerlund M
Acta Obstet Gynecol Scand; 1989; 68(1):31-4. PubMed ID: 2801028
[TBL] [Abstract][Full Text] [Related]
3. Application of selective estrogen receptor modulators for breast cancer treatment according to their intrinsic nature.
Saji S; Kuroi K
Breast Cancer; 2008; 15(4):262-9. PubMed ID: 18654829
[TBL] [Abstract][Full Text] [Related]
4. Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.
Ganz PA; Land SR
Menopause; 2008; 15(4 Suppl):797-803. PubMed ID: 18596601
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.
Dihge L; Bendahl PO; Grabau D; Isola J; Lövgren K; Rydén L; Fernö M
Breast Cancer Res Treat; 2008 May; 109(2):255-62. PubMed ID: 17636398
[TBL] [Abstract][Full Text] [Related]
6. [Influence of naloxone on uterine contractions in patients with primary dysmenorrhea].
Mrugacz G; Grygoruk C; Sieczyński P; Grusza M; Pietrewicz P; Pietrzycki B
Pol Merkur Lekarski; 2013 Sep; 35(207):151-3. PubMed ID: 24224452
[TBL] [Abstract][Full Text] [Related]
7. Dysmenorrhea in adolescents.
Harel Z
Ann N Y Acad Sci; 2008; 1135():185-95. PubMed ID: 18574224
[TBL] [Abstract][Full Text] [Related]
8. Zinc treatment prevents dysmenorrhea.
Eby GA
Med Hypotheses; 2007; 69(2):297-301. PubMed ID: 17289285
[TBL] [Abstract][Full Text] [Related]
9. Dysmenorrhea in adolescents and young adults: etiology and management.
Harel Z
J Pediatr Adolesc Gynecol; 2006 Dec; 19(6):363-71. PubMed ID: 17174824
[TBL] [Abstract][Full Text] [Related]
10. HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information.
Rydén L; Landberg G; Stål O; Nordenskjöld B; Fernö M; Bendahl PO
Breast Cancer Res Treat; 2008 May; 109(2):351-7. PubMed ID: 17636399
[TBL] [Abstract][Full Text] [Related]
11. Validation of a test model of induced dysmenorrhea.
Liedman R; Skillern L; James I; McLeod A; Grant L; Akerlund M
Acta Obstet Gynecol Scand; 2006; 85(4):451-7. PubMed ID: 16612708
[TBL] [Abstract][Full Text] [Related]
12. Recent results from clinical trials using SERMs to reduce the risk of breast cancer.
Vogel VG
Ann N Y Acad Sci; 2006 Nov; 1089():127-42. PubMed ID: 17261762
[TBL] [Abstract][Full Text] [Related]
13. The effect of oral contraceptives on uterine contractility and menstrual pain: an assessment with cine MR imaging.
Kido A; Togashi K; Kataoka M; Maetani Y; Nakai A; Kataoka ML; Koyama T; Fujii S
Hum Reprod; 2007 Jul; 22(7):2066-71. PubMed ID: 17567596
[TBL] [Abstract][Full Text] [Related]
14. Primary dysmenorrhea: current concepts.
Voto SJ; Essig GF
Ohio State Med J; 1984 Aug; 80(8):606-9. PubMed ID: 6462599
[TBL] [Abstract][Full Text] [Related]
15. [Dysmenorrhea induced by lumbosacral spine disorders. Pathogenesis, diagnosis and therapy with special emphasis on spinal manipulative therapy].
Grgić V
Lijec Vjesn; 2009; 131(9-10):275-9. PubMed ID: 20030292
[TBL] [Abstract][Full Text] [Related]
16. Primary dysmenorrhea: advances in pathogenesis and management.
Dawood MY
Obstet Gynecol; 2006 Aug; 108(2):428-41. PubMed ID: 16880317
[TBL] [Abstract][Full Text] [Related]
17. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial.
Harada T; Momoeda M; Taketani Y; Hoshiai H; Terakawa N
Fertil Steril; 2008 Nov; 90(5):1583-8. PubMed ID: 18164001
[TBL] [Abstract][Full Text] [Related]
18. Non-steroidal anti-estrogens in the treatment of breast cancer.
Barker S
Curr Opin Investig Drugs; 2006 Dec; 7(12):1085-91. PubMed ID: 17209526
[TBL] [Abstract][Full Text] [Related]
19. Drug insight: breast cancer prevention and tissue-targeted hormone replacement therapy.
Labrie F
Nat Clin Pract Endocrinol Metab; 2007 Aug; 3(8):584-93. PubMed ID: 17643129
[TBL] [Abstract][Full Text] [Related]
20. A rationale for the treatment of dysmenorrhea.
Csapo AI
J Reprod Med; 1980 Oct; 25(4 Suppl):213-21. PubMed ID: 7001020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
